Responses
Immune cell therapies and immune cell engineering
Original research
Knockout of the inhibitory receptor TIGIT enhances the antitumor response of ex vivo expanded NK cells and prevents fratricide with therapeutic Fc-active TIGIT antibodies
Compose a Response to This Article
Other responses
No responses have been published for this article.
